The trajectory of Viagra, originally marketed by copyright, presents a fascinating case study for backers considering the drug sector. Although its early success and generation of billions in revenue , the patent lapse has opened the floodgates for competing medications, significantly diminishing profit opportunities. This change raises doubts abou